Bloomage BioTechnology Corp Ltd 2016 AR2
The report highlights Bloomage BioTechnology Corporation Limited's financial and ESG performance for the fiscal year 2016. The company achieved a 29.7% increase in annual revenue to RMB 844.39 million, driven by the expansion of its hyaluronic acid raw materials and end products business. On the sustainability front, the company implemented 12 clean production schemes, resulting in zero environmental pollution accidents. Additionally, Bloomage Biopharm obtained a level 3 safety standard inspection certificate and was recognized for its fire safety and environmental efforts.
Company: Bloomage BioTechnology Corp Ltd
Sector: Consumer Staples
Country: China
Year: 2016
Type: AR2
Pages: 165
Bloomage BioTechnology Corp Ltd
Annual Report
The report highlights Bloomage BioTechnology Corporation Limited's financial and ESG performance for the fiscal year 2016. The company achieved a 29.7% increase in annual revenue to RMB 844.39 million, driven by the expansion of its hyaluronic acid raw materials and end products business. On the sustainability front, the company implemented 12 clean production schemes, resulting in zero environmental pollution accidents. Additionally, Bloomage Biopharm obtained a level 3 safety standard inspection certificate and was recognized for its fire safety and environmental efforts.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2016
Reporting Period
Jan 1, 2016 - Dec 31, 2016
Fiscal Year
2016
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Employees